Watchtower Advisors LP Raises Position in CVS Health Corporation $CVS

Watchtower Advisors LP increased its stake in CVS Health Corporation (NYSE:CVS) by 37.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 357,000 shares of the pharmacy operator’s stock after buying an additional 97,000 shares during the period. CVS Health comprises 12.6% of Watchtower Advisors LP’s holdings, making the stock its largest position. Watchtower Advisors LP’s holdings in CVS Health were worth $26,914,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Financial Life Planners bought a new position in shares of CVS Health during the 3rd quarter valued at $49,000. Van ECK Associates Corp grew its holdings in shares of CVS Health by 19.0% in the third quarter. Van ECK Associates Corp now owns 1,307,896 shares of the pharmacy operator’s stock worth $98,602,000 after acquiring an additional 209,081 shares during the period. LifePlan Financial LLC increased its position in CVS Health by 7.8% during the third quarter. LifePlan Financial LLC now owns 22,486 shares of the pharmacy operator’s stock valued at $1,695,000 after acquiring an additional 1,620 shares during the last quarter. Tiemann Investment Advisors LLC bought a new position in CVS Health in the third quarter valued at about $215,000. Finally, Capital Research Global Investors boosted its position in CVS Health by 24.5% in the third quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock worth $864,667,000 after purchasing an additional 2,253,531 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CVS. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Piper Sandler restated an “overweight” rating and set a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Finally, The Goldman Sachs Group boosted their price objective on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Trading Down 0.8%

CVS Health stock opened at $75.74 on Thursday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15. The firm has a market capitalization of $96.35 billion, a price-to-earnings ratio of 54.88, a P/E/G ratio of 0.80 and a beta of 0.49. The firm has a 50 day moving average of $78.31 and a 200 day moving average of $77.72.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The company’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the prior year, the company posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s dividend payout ratio is 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.